Literature DB >> 32221039

H and L Chain Affinity Maturation and/or Fab N-Glycosylation Influence Immunoreactivity toward Neutrophil Extracellular Trap Antigens in Rheumatoid Arthritis Synovial B Cell Clones.

Elisa Corsiero1, Emanuela Carlotti2, Lucas Jagemann2, Mauro Perretti3, Costantino Pitzalis2, Michele Bombardieri1.   

Abstract

We previously showed that anti-neutrophil extracellular trap (NET) rheumatoid arthritis (RA)-rmAbs derived from CD19+ B cells within RA human synovial tissues frequently react against NETs. In this study, we aimed to characterize the importance of affinity maturation via somatic hypermutation (SHM) within the Ig variable H (VH) and variable L (VL) chains and Fab-N-linked glycosylation in RA synovial B cell clones reactive to NETs and NET-derived Ags such as citrullinated histones. Selected anti-NET RA-rmAbs derived from synovial RA CD19+ B cells were subjected to overlap-PCR to generate germline (GL; VH and VL reverted into GL), hybrid clones (VH/VL region reverted into GL), and N-glycosylation mutants (N→Q) and analyzed for anti-NETs and citrullinated histones (cit-H2B) immunoreactivity. Anti-NET/cit-H2B immunoreactivity of selected RA-rmAbs was abrogated in the VH and VL GL counterpart. In RA B cell hybrid clone RA015/11.88 and RA056/11.23.2, NET and/or cit-H2B immunoreactivity was solely dependent on SHM in the IgVH region whereas RA B cell hybrid clone RA015/11.91 required affinity maturation of both VH and VL for efficient binding to cit-H2B. In 7/80 RA-rmAb, SHM resulted in ex novo N-glycosylation sites in VH and/or VL regions. Removal of Fab-linked glycans in RA056/11.23.2 in the N-mutant counterpart resulted in 90% reduction in immunoreactivity to cit-H2B. Thus, SHM in the IgVH and/or VL regions of RA synovial B cells is necessary for the immunoreactivity to NET-Ags. Fab-N-linked-glycosylation introduction sites are observed in a minority of anti-NET B cell clones but can strongly influence NET-Ag binding.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32221039      PMCID: PMC7167462          DOI: 10.4049/jimmunol.1901457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

2.  Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Authors:  Yoann Rombouts; Annemiek Willemze; Joyce J B C van Beers; Jing Shi; Priscilla F Kerkman; Linda van Toorn; George M C Janssen; Arnaud Zaldumbide; Rob C Hoeben; Ger J M Pruijn; André M Deelder; Gertjan Wolbink; Theo Rispens; Peter A van Veelen; Tom W J Huizinga; Manfred Wuhrer; Leendert A Trouw; Hans U Scherer; René E M Toes
Journal:  Ann Rheum Dis       Date:  2015-01-13       Impact factor: 19.103

3.  Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.

Authors:  Sarah Kongpachith; Nithya Lingampalli; Chia-Hsin Ju; Lisa K Blum; Daniel R Lu; Serra E Elliott; Rong Mao; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2019-02-27       Impact factor: 10.995

4.  Affinity Maturation Drives Epitope Spreading and Generation of Proinflammatory Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis.

Authors:  Serra E Elliott; Sarah Kongpachith; Nithya Lingampalli; Julia Z Adamska; Bryan J Cannon; Rong Mao; Lisa K Blum; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2018-10-20       Impact factor: 10.995

5.  V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis.

Authors:  Tobias Scheel; Angelika Gursche; Josef Zacher; Thomas Häupl; Claudia Berek
Journal:  Arthritis Rheum       Date:  2011-01

6.  N-Glycosylation Site Analysis of Citrullinated Antigen-Specific B-Cell Receptors Indicates Alternative Selection Pathways During Autoreactive B-Cell Development.

Authors:  Rochelle D Vergroesen; Linda M Slot; Barbera D C van Schaik; Marvyn T Koning; Theo Rispens; Antoine H C van Kampen; René E M Toes; Hans U Scherer
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

7.  Generation of Recombinant Monoclonal Antibodies from Single B Cells Isolated from Synovial Tissue of Rheumatoid Arthritis Patients.

Authors:  Elisa Corsiero; Lucas Jagemann; Michele Bombardieri; Costantino Pitzalis
Journal:  Methods Mol Biol       Date:  2018

8.  Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE).

Authors:  Sergey Lyskov; Fang-Chieh Chou; Shane Ó Conchúir; Bryan S Der; Kevin Drew; Daisuke Kuroda; Jianqing Xu; Brian D Weitzner; P Douglas Renfrew; Parin Sripakdeevong; Benjamin Borgo; James J Havranek; Brian Kuhlman; Tanja Kortemme; Richard Bonneau; Jeffrey J Gray; Rhiju Das
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.

Authors:  Elisa Corsiero; Michele Bombardieri; Emanuela Carlotti; Federico Pratesi; William Robinson; Paola Migliorini; Costantino Pitzalis
Journal:  Ann Rheum Dis       Date:  2015-12-09       Impact factor: 19.103

10.  Characterization of a Synovial B Cell-Derived Recombinant Monoclonal Antibody Targeting Stromal Calreticulin in the Rheumatoid Joints.

Authors:  Elisa Corsiero; Lucas Jagemann; Mauro Perretti; Costantino Pitzalis; Michele Bombardieri
Journal:  J Immunol       Date:  2018-07-25       Impact factor: 5.422

View more
  3 in total

Review 1.  Neutrophil Extracellular Traps Tied to Rheumatoid Arthritis: Points to Ponder.

Authors:  Wenpeng Song; Jing Ye; Nanfang Pan; Chunyu Tan; Martin Herrmann
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 2.  Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation.

Authors:  Elizabeth Edwards; Maria Livanos; Anja Krueger; Anne Dell; Stuart M Haslam; C Mark Smales; Daniel G Bracewell
Journal:  Biotechnol Bioeng       Date:  2022-02-28       Impact factor: 4.395

Review 3.  Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings.

Authors:  Maria V Sokolova; Georg Schett; Ulrike Steffen
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-08       Impact factor: 10.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.